|
1
|
Keum N and Giovannucci E: Global burden of
colorectal cancer: Emerging trends, risk factors and prevention
strategies. Nat Rev Gastroenterol Hepatol. 16:713–732. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dekker E, Tanis PJ, Vleugels JLA, Kasi PM
and Wallace MB: Colorectal cancer. Lancet. 394:1467–1480. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kuipers EJ, Grady WM, Lieberman D,
Seufferlein T, Sung JJ, Boelens PG, van de Velde CJ and Watanabe T:
Colorectal cancer. Nat Rev Dis Primers. 1:150652015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Martini G, Troiani T, Cardone C, Vitiello
P, Sforza V, Ciardiello D, Napolitano S, Della Corte CM, Morgillo
F, Raucci A, et al: Present and future of metastatic colorectal
cancer treatment: A review of new candidate targets. World J
Gastroenterol. 23:4675–4688. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Locke WJ, Guanzon D, Ma C, Liew YJ,
Duesing KR, Fung KYC and Ross JP: DNA methylation cancer
biomarkers: Translation to the clinic. Front Genet. 10:11502019.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chakraborty S, Hosen MI, Ahmed M and
Shekhar HU: Onco-multi-OMICS approach: A new frontier in cancer
research. Biomed Res Int. 2018:98362562018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cao XP, Cao Y, Li WJ, Zhang HH and Zhu ZM:
P4HA1/HIF1alpha feedback loop drives the glycolytic and malignant
phenotypes of pancreatic cancer. Biochem Biophys Res Commun.
516:606–612. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu R: P4HA1 is a new regulator of the
HIF-1 pathway in breast cancer. Cell Stress. 3:27–28. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xiong G, Stewart RL, Chen J, Gao T, Scott
TL, Samayoa LM, O'Connor K, Lane AN and Xu R: Collagen prolyl
4-hydroxylase 1 is essential for HIF-1alpha stabilization and TNBC
chemoresistance. Nat Commun. 9:44562018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chakravarthi BV, Pathi SS, Goswami MT,
Cieślik M, Zheng H, Nallasivam S, Arekapudi SR, Jing X, Siddiqui J,
Athanikar J, et al: The miR-124-prolyl hydroxylase P4HA1-MMP1 axis
plays a critical role in prostate cancer progression. Oncotarget.
5:6654–6669. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schatoff EM, Leach BI and Dow LE: Wnt
signaling and colorectal cancer. Curr Colorectal Cancer Rep.
13:101–110. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhan T, Rindtorff N and Boutros M: Wnt
signaling in cancer. Oncogene. 36:1461–1473. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yoshida N, Kinugasa T, Ohshima K, Yuge K,
Ohchi T, Fujino S, Shiraiwa S, Katagiri M and Akagi Y: Analysis of
Wnt and beta-catenin expression in advanced colorectal cancer.
Anticancer Res. 35:4403–4410. 2015.PubMed/NCBI
|
|
16
|
Khamas A, Ishikawa T, Shimokawa K, Mogushi
K, Iida S, Ishiguro M, Mizushima H, Tanaka H, Uetake H and Sugihara
K: Screening for epigenetically masked genes in colorectal cancer
Using 5-Aza-2′-deoxycytidine, microarray and gene expression
profile. Cancer Genomics Proteomics. 9:67–75. 2012.PubMed/NCBI
|
|
17
|
Danielsen SA, Cekaite L, Ågesen TH, Sveen
A, Nesbakken A, Thiis-Evensen E, Skotheim RI, Lind GE and Lothe RA:
Phospholipase C isozymes are deregulated in colorectal
cancer-insights gained from gene set enrichment analysis of the
transcriptome. PLoS One. 6:e244192011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Flejou JF: WHO Classification of digestive
tumors: The fourth edition. Ann Pathol. 31 (Suppl 5):S27–S31.
2011.(In French). PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nagaraju GP, Bramhachari PV, Raghu G and
El-Rayes BF: Hypoxia inducible factor-1alpha: Its role in
colorectal carcinogenesis and metastasis. Cancer Lett. 366:11–18.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Giles RH, Lolkema MP, Snijckers CM,
Belderbos M, van der Groep P, Mans DA, van Beest M, van Noort M,
Goldschmeding R, van Diest PJ, et al: Interplay between
VHL/HIF1alpha and Wnt/beta-catenin pathways during colorectal
tumorigenesis. Oncogene. 25:3065–3070. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-update. Nucleic Acids Res. 41((Database issue)):
D991–D995. 2013.PubMed/NCBI
|
|
23
|
Ågesen TH, Berg M, Clancy T, Thiis-Evensen
E, Cekaite L, Lind GE, Nesland JM, Bakka A, Mala T, Hauss HJ, et
al: CLC and IFNAR1 are differentially expressed and a global
immunity score is distinct between early- and late-onset colorectal
cancer. Genes Immun. 12:653–662. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hu WM, Zhang J, Sun SX, Xi SY, Chen ZJ,
Jiang XB, Lin FH, Chen ZH, Chen YS, Wang J, et al: Identification
of P4HA1 as a prognostic biomarker for high-grade gliomas. Pathol
Res Pract. 213:1365–1369. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kappler M, Kotrba J, Kaune T, Bache M, Rot
S, Bethmann D, Wichmann H, Güttler A, Bilkenroth U, Horter S, et
al: P4HA1: A single-gene surrogate of hypoxia signatures in oral
squamous cell carcinoma patients. Clin Transl Radiat Oncol. 5:6–11.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Agarwal S, Behring M, Kim HG, Bajpai P,
Chakravarthi BVSK, Gupta N, Elkholy A, Al Diffalha S, Varambally S
and Manne U: Targeting P4HA1 with a small molecule inhibitor in a
colorectal cancer PDX model. Transl Oncol. 13:1007542020.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xiang L, Mou J, Shao B, Wei Y, Liang H,
Takano N, Semenza GL and Xie G: Glutaminase 1 expression in
colorectal cancer cells is induced by hypoxia and required for
tumor growth, invasion, and metastatic colonization. Cell Death
Dis. 10:402019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Frantz C, Stewart KM and Weaver VM: The
extracellular matrix at a glance. J Cell Sci. 123:4195–4200. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Begum A, Ewachiw T, Jung C, Huang A,
Norberg KJ, Marchionni L, McMillan R, Penchev V, Rajeshkumar NV,
Maitra A, et al: The extracellular matrix and focal adhesion kinase
signaling regulate cancer stem cell function in pancreatic ductal
adenocarcinoma. PLoS One. 12:e01801812017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Poltavets V, Kochetkova M, Pitson SM and
Samuel MS: The role of the extracellular matrix and its molecular
and cellular regulators in cancer cell plasticity. Front Oncol.
8:4312018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Somaiah C, Kumar A, Mawrie D, Sharma A,
Patil SD, Bhattacharyya J, Swaminathan R and Jaganathan BG:
Collagen promotes higher adhesion, survival and proliferation of
mesenchymal stem cells. PLoS One. 10:e01450682015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nallanthighal S, Heiserman JP and Cheon
DJ: The role of the extracellular matrix in cancer stemness. Front
Cell Dev Biol. 7:862019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zou Y, Donkervoort S, Salo AM, Foley AR,
Barnes AM, Hu Y, Makareeva E, Leach ME, Mohassel P, Dastgir J, et
al: P4HA1 mutations cause a unique congenital disorder of
connective tissue involving tendon, bone, muscle and the eye. Hum
Mol Genet. 26:2207–2217. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhao X and Guan JL: Focal adhesion kinase
and its signaling pathways in cell migration and angiogenesis. Adv
Drug Deliv Rev. 63:610–615. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Baba Y, Nosho K, Shima K, Irahara N, Chan
AT, Meyerhardt JA, Chung DC, Giovannucci EL, Fuchs CS and Ogino S:
HIF1A overexpression is associated with poor prognosis in a cohort
of 731 colorectal cancers. Am J Pathol. 176:2292–2301. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Huang ZY, Zhang LH, Zhao C, Liu R, Tong H,
Gan C, Lan T, Tang CW and Gao JH: High HIF-1α expression predicts
poor prognosis of patients with colon adenocarcinoma. Int J Clin
Exp Pathol. 11:5635–5646. 2018.PubMed/NCBI
|
|
37
|
Xu W, Zhou W, Cheng M, Wang J, Liu Z, He
S, Luo X, Huang W, Chen T, Yan W and Xiao J: Hypoxia activates
Wnt/β-catenin signaling by regulating the expression of BCL9 in
human hepatocellular carcinoma. Sci Rep. 7:404462017. View Article : Google Scholar : PubMed/NCBI
|
